Bradner James E. has filed 8 insider transactions across 1 company since February 2024.
Most recent transaction: a tax payment of 953 shares of AMGEN INC ($AMGN) on February 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 9, 2026 | AMGEN INC | $AMGN | Bradner James E. | EVP, Research and Development | F | Common Stock | 953 | $384.32 | 27,378.0000 | 538,800,000 | 3.36% | 0.00% |
| Feb. 9, 2026 | AMGEN INC | $AMGN | Bradner James E. | EVP, Research and Development | F | Common Stock | 2151 | $384.32 | 28,331.0000 | 538,800,000 | 7.06% | 0.00% |
| May 6, 2025 | AMGEN INC | $AMGN | Bradner James E. | EVP, R&D, & Chief Sci. Officer | A | Common Stock | 3549 | $0.00 | 29,753.0000 | 536,900,000 | 13.54% | 0.00% |
| May 6, 2025 | AMGEN INC | $AMGN | Bradner James E. | EVP, R&D, & Chief Sci. Officer | A | Nqso (Right to Buy) | 22944 | $270.44 | 22,944.0000 | 536,900,000 | 9999.99% | 0.00% |
| May 7, 2024 | AMGEN INC | $AMGN | Bradner James E. | EVP, R&D, & Chief Sci. Officer | A | Nqso (Right to Buy) | 18603 | $300.30 | 18,603.0000 | 535,400,000 | 9999.99% | 0.00% |
| May 7, 2024 | AMGEN INC | $AMGN | Bradner James E. | EVP, R&D, & Chief Sci. Officer | A | Common Stock | 2863 | $0.00 | 25,438.0000 | 535,400,000 | 12.68% | 0.00% |
| Feb. 9, 2024 | AMGEN INC | $AMGN | Bradner James E. | EVP, R&D, & Chief Sci. Officer | A | Common Stock | 8587 | $0.00 | 8,587.0000 | 535,400,000 | 9999.99% | 0.00% |
| Feb. 9, 2024 | AMGEN INC | $AMGN | Bradner James E. | EVP, R&D, & Chief Sci. Officer | A | Common Stock | 13806 | $0.00 | 22,393.0000 | 535,400,000 | 160.78% | 0.00% |